Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
55.77
Dollar change
+0.59
Percentage change
1.07
%
IndexRUT P/E- EPS (ttm)-3.74 Insider Own58.94% Shs Outstand17.40M Perf Week3.70%
Market Cap1.35B Forward P/E- EPS next Y-4.19 Insider Trans-12.89% Shs Float9.91M Perf Month21.27%
Income-74.08M PEG- EPS next Q-0.77 Inst Own44.61% Short Float / Ratio12.13% / 6.51 Perf Quarter6.23%
Sales0.00M P/S- EPS this Y92.78% Inst Trans4.35% Short Interest1.20M Perf Half Y37.13%
Book/sh14.87 P/B3.75 EPS next Y-28.79% ROA-30.70% Target Price67.11 Perf Year224.24%
Cash/sh15.35 P/C3.63 EPS next 5Y- ROE-31.96% 52W Range11.80 - 57.70 Perf YTD180.39%
Dividend- P/FCF- EPS past 5Y- ROI-20.54% 52W High-3.34% Beta0.16
Dividend %- Quick Ratio25.96 Sales past 5Y0.00% Gross Margin- 52W Low372.63% ATR2.41
Employees46 Current Ratio25.96 Sales Q/Q- Oper. Margin0.00% RSI (14)66.83 Volatility3.58% 4.91%
OptionableYes Debt/Eq0.01 EPS Q/Q23.32% Profit Margin- Rel Volume0.81 Prev Close55.18
ShortableYes LT Debt/Eq0.00 EarningsNov 09 BMO Payout- Avg Volume184.76K Price55.77
Recom1.00 SMA209.84% SMA5016.23% SMA20036.72% Volume149,388 Change1.07%
Date Action Analyst Rating Change Price Target Change
Jun-09-23Upgrade Raymond James Outperform → Strong Buy $50 → $75
Jun-07-23Initiated H.C. Wainwright Buy $55
May-17-23Initiated Raymond James Outperform $50
Apr-28-23Initiated Cantor Fitzgerald Overweight $45
Apr-21-23Initiated Stifel Buy $37
Apr-20-23Initiated Morgan Stanley Overweight $37
Mar-23-23Initiated BMO Capital Markets Outperform $40
Feb-28-23Initiated SVB Securities Outperform $36
Nov-14-23 04:44PM
Nov-13-23 09:55AM
Nov-09-23 09:34AM
08:30AM
Nov-08-23 04:30PM
09:00AM Loading…
Nov-02-23 09:00AM
Oct-23-23 09:15AM
Oct-03-23 08:30AM
Sep-20-23 04:30PM
Aug-30-23 04:15PM
Aug-24-23 11:20AM
Aug-11-23 08:50AM
08:00AM
Jul-27-23 09:00AM
Jul-25-23 09:55AM
04:15PM Loading…
Jun-22-23 04:15PM
Jun-20-23 07:33PM
Jun-13-23 10:39PM
Jun-12-23 04:00PM
01:59AM
Jun-09-23 04:13PM
07:00AM
Jun-01-23 03:10PM
May-31-23 04:00PM
May-15-23 07:00AM
May-11-23 10:15AM
May-10-23 10:23AM
May-05-23 08:50AM
May-04-23 12:00PM
Apr-28-23 05:00AM
08:05AM Loading…
Apr-27-23 08:05AM
Apr-21-23 08:30AM
Apr-19-23 08:50AM
Apr-13-23 11:00AM
Mar-31-23 07:00AM
Mar-30-23 07:05AM
Mar-21-23 07:00AM
Feb-16-23 08:00AM
Feb-14-23 06:30AM
Feb-08-23 04:00PM
Jan-20-23 07:00AM
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel treatments for hematologic disorders. Its programs include Bitopertin, DISC-0974, and DISC-3405. The company was founded in October 2017 and is headquartered in Watertown, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Khara RahulGeneral CounselNov 22Option Exercise14.6910,000146,90010,000Nov 27 04:15 PM
Khara RahulGeneral CounselNov 22Sale51.7310,000517,3330Nov 27 04:15 PM
Khara RahulGeneral CounselNov 14Option Exercise14.694,90071,9814,900Nov 15 05:00 PM
Khara RahulGeneral CounselNov 14Sale50.614,900248,0120Nov 15 05:00 PM
Khara RahulGeneral CounselNov 03Option Exercise14.691001,469100Nov 07 06:22 PM
Khara RahulGeneral CounselNov 03Sale50.001005,0000Nov 07 06:22 PM
Atlas Venture Fund X, L.P.10% OwnerSep 16Sale53.222,115112,5601,593,785Sep 18 04:59 PM
Atlas Venture Fund X, L.P.10% OwnerSep 15Sale53.16260,89413,869,1251,595,900Sep 18 04:59 PM
Atlas Venture Fund X, L.P.10% OwnerSep 14Sale53.0594,4405,010,0421,856,794Sep 18 04:59 PM
Bryce JoanneChief Financial OfficerSep 11Option Exercise9.862,50024,6503,760Sep 13 04:15 PM
Bryce JoanneChief Financial OfficerSep 01Option Exercise2.651,0002,6502,260Sep 05 04:16 PM
Bryce JoanneChief Financial OfficerSep 01Sale52.991,00052,9901,260Sep 05 04:16 PM
Savage William JacobChief Medical OfficerAug 21Option Exercise2.653,0007,9503,000Aug 22 04:06 PM
Atlas Venture Fund X, L.P.10% OwnerAug 15Sale52.40111,0695,820,0161,951,234Aug 16 06:55 PM
Bitterman KevinDirectorAug 15Sale52.4072,9313,821,584882,224Aug 17 04:13 PM
Atlas Venture Fund X, L.P.10% OwnerAug 15Sale52.4072,9313,821,584882,224Aug 16 06:55 PM
Savage William JacobChief Medical OfficerAug 15Sale52.957,672406,2350Aug 16 04:15 PM
Atlas Venture Fund X, L.P.10% OwnerAug 14Sale52.59175,0009,203,6002,062,303Aug 16 06:55 PM
Savage William JacobChief Medical OfficerAug 09Sale49.838,269412,0647,672Aug 11 04:15 PM
Bryce JoanneChief Financial OfficerAug 01Option Exercise1.014,5214,5665,781Aug 03 04:18 PM
Bryce JoanneChief Financial OfficerAug 01Sale49.914,521225,6331,260Aug 03 04:18 PM
MacDonald Brian RichardChief Innovation OfficerJun 30Sale45.054,324194,77812,876Jun 30 06:29 PM
MacDonald Brian RichardChief Innovation OfficerJun 29Sale45.795,100233,50917,200Jun 30 06:29 PM
Bryce JoanneChief Financial OfficerJun 28Option Exercise1.017,8807,95911,332Jun 30 04:49 PM
Novo Holdings A/S10% OwnerJun 28Sale46.101,250,00057,625,0001,090,772Jun 28 05:04 PM
Bryce JoanneChief Financial OfficerJun 28Sale49.9510,072503,1141,260Jun 30 04:49 PM
MacDonald Brian RichardChief Innovation OfficerJun 28Sale49.965,100254,79522,300Jun 30 06:29 PM
Savage William JacobChief Medical OfficerJun 28Sale49.984,384219,11415,941Jun 30 04:12 PM
AI DMI LLC10% OwnerFeb 15Buy23.00434,78310,000,0093,141,759Feb 17 04:42 PM
Ashiya MonaDirectorFeb 15Buy23.00108,6962,500,0081,196,825Feb 17 04:48 PM
ORBIMED ADVISORS LLCDirectorFeb 15Buy23.00108,6962,500,0081,196,825Feb 17 04:43 PM